Peculiarities of food sensitization in patients having bronchial asthma in combinationwith Helicobacter pylori-associated chronic gastritis


DOI: https://dx.doi.org/10.18565/therapy.2024.2.20-24

Pozdnyakova O.Yu., Dyshekova N.V., Dokhkaeva A.Z.

Stavropol State Medical University of the Ministry of Healthcare of Russia
Abstract. Currently, there are very few studies on the frequency and nature of food sensitization in cases of isolated bronchial asthma (BA) and BA in combination with H. pylori-associated chronic gastritis (Hp-ACG).
The aim: to estimate the frequency and nature of food sensitization in patients with isolated BA and BA in combination with Hp-ACG.
Material and methods. 85 patients with bronchial asthma (BA) were divided into two groups: 1st group (main) – patients with BA in combination with Hp-ACG (n = 50), 2nd – patients with isolated BA (n = 35). All the participants of the research underwent clinical, laboratory, instrumental and allergological examination.
Results. In patients with isolated BA and BA in combination with Hp-ACG, very high and high levels of specific IgE and IgG to various food allergens (cow’s milk, pork, beef, chicken, cod, wheat, buckwheat, oatmeal) were identified. The most clinically significant food sensitization was observed in patients with severe uncontrolled BA in combination with Hp-ACG.
Conclusion. Food sensitization is a characteristic feature in patients with isolated BA and BA in combination with Hp-ACG. In case of severe persistent clinical course, frequent BA exacerbations, lack of the control over disease, it is necessary to check the level of total IgE and specific food IgE and IgG to study the nature and frequency of food sensitization and also for performing rational pharmacotherapy for patients with both isolated BA and in the case of comorbidity of BA with Hp-AHG.
Keywords: specific food IgE and IgG, H. pylori-associated chronic gastritis, food sensitization, bronchial asthma
Read entire article

Literature

1. Ma Z.F., Majid N.A., Yamaoka Y., Lee Y.Y. Food allergy and Helicobacter pylori infection: A systematic review. Front Microbiol. 2016; 7: 368.


https://doi.org/10.3389/fmicb.2016.00368. PMID: 27047479. PMCID: PMC4804492.


2. Liu M., Wang Y., Du B. Update on the association between Helicobacter pylori infection and asthma in terms of microbiota and immunity. Allergy Asthma Clin Immunol. 2024; 20(1): 4.


https://doi.org/10.1186/s13223-024-00870-2. PMID: 38221621. PMCID: PMC10788013.


3. Okada H., Kuhn C., Feillet H., Bach J.F. The “hygiene hypothesis” for autoimmune and allergic diseases: An update. Clin Exp Immunol. 2010; 160(1): 1–9.


https://doi.org/10.1111/j.1365-2249.2010,04139.x. PMID: 20415844. PMCID: PMC2841828.


4. Zhou X., Wu J., Zhang G. Association between Helicobacter pylori and asthma: A meta-analysis. Eur J Gastroenterol Hepatol. 2013; 25(4): 460–68.


https://doi.org/10.1097/MEG.0b013e32835c280a. PMID: 23242126.


5. Van Wijck Y., de Kleijn S., John-Schuster G. et al. Therapeutic application of an extract of Helicobacter pylori ameliorates the development of allergic airway disease. J Immunol. 2018; 200(5): 1570–79.


https://doi.org/10.4049/jimmunol.1700987. PMID: 29352004.


6. Kyburz A., Urban S., Altobelli A. et al. Helicobacter pylori and its secreted immunomodulator VacA protect against anaphylaxis in experimental models of food allergy. Clin Exp Allergy. 2017; 47(10): 1331–41.


https://doi.org/10.1111/cea.12996. PMID: 28802077. PMCID: PMC5623135.


7. Amberbir A., Medhin G., Abegaz W.E. et al. Exposure to Helicobacter pylori infection in early childhood and the risk of allergic disease and atopic sensitization: A longitudinal birth cohort study. Clin Exp Allergy. 2014; 44(4): 563–71.


https://doi.org/10.1111/cea.12289. PMID: 24528371. PMCID: PMC4164268.


8. Позднякова О.Ю., Батурин В.А. Особенности пищевой, бактериальной и микогенной сенсибилизации у пациентов с неконтролируемой бронхиальной астмой. Российский аллергологический журнал. 2013; (2–2): 235–236. (Pozdnyakova O.Yu., Baturin V.A. Features of food, bacterial and mycogenic sensitization in patients with uncontrolled bronchial asthma. Rossiyskiy allergologicheskiy zhurnal = Russian Journal of Allergy. 2013; (2–2): 235–236 (in Russ.)). EDN: SGKXUR.


9. Mai J., Liang B., Xiong Z. et al. Oral administration of recombinant Bacillus subtilis spores expressing Helicobacter pylori neutrophil-activating protein suppresses peanut allergy via up-regulation of Tregs. Clin Exp Allergy. 2019; 49(12): 1605–14.


https://doi.org/10.1111/cea.13489. PMID: 31468633.


10. Sommer F., Faller G., Konturek P. et al. Antrum- and corpus mucosa-infiltrating CD4 (+) lymphocytes in Helicobacter pylori gastritis display a Th1phenotype. Infect Immun. 1998; 66(11): 5543–46.


https://doi.org/10.1128/IAI.66.11.5543-5546.1998. PMID: 9784570. PMCID: PMC108696.


11. Arnold I.C., Dehzad N., Reuter S. et al. Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T-cells. J Clin Invest. 2011; 121(8): 3088–93.


https://doi.org/10.1172/JCI45041. PMID: 21737881. PMCID: PMC3148731.


12. Маев И.В., Бакулин И.Г., Курилович С.А. с соавт. Helicobacter pylori и экстрагастродуоденальные заболевания: доказанные факты и предположения. Доказательная гастроэнтерология. 2018; 7(3): 45–59. (Maev I.V., Bakulin I.G., Kurilovich S.A. et al. Helicobacter pylori and extragastroduodenal diseases: The proven facts and assumptions. Dokazatel’naya gastroenterologiya = Russian Journal of Evidence-Based Gastroenterology. 2018; 7(3): 45–59 (In Russ.)).


https://doi.org/10.17116/dokgastro2018703145. EDN: YLSRKH.


13. Клинические рекомендации. Бронхиальная астма. Российское респираторное общество, Российская ассоциация аллергологов и клинических иммунологов, Союз педиатров России. Рубрикатор клинических рекомендаций Минздрава России. 2021. ID: 359. Доступ: https://cr.minzdrav.gov.ru/schema/359_2 (дата обращения – 01.02.2024). (Clinical guidelines. Bronchial asthma. Russian Respiratory Society, Russian Association of Allergists and Clinical Immunologists, Union of Pediatricians of Russia. Rubricator of clinical guidelines of the Ministry of Healthcare of Russia. 2021. ID: 359. URL: https://cr.minzdrav.gov.ru/schema/359_2 (date of access – 01.02.2024) (In Russ.)).


About the Autors

Oksana Yu. Pozdnyakova, MD, Dr. Sci. (Medicine), professor of the Department of clinical pharmacology with a course of additional professional education, Stavropol State Medical University of the Ministry of Healthcare of Russia. Address: 355017, Stavropol, 310 Mira St.
E-mail: oxana_stav@mail.ru
ORCID: https://orcid.org/0000-0002-0208-7993
Natalya V. Dyshekova, MD, postgraduate student of the Department of clinical pharmacology with a course of additional professional education, Stavropol State Medical University of the Ministry of Healthcare of Russia. Address: 355017, Stavropol, 310 Mira St.
E-mail: natalia.glebova9@yandex.ru
Aza Z. Dokhkaeva, MD, postgraduate student of the Department of clinical pharmacology with a course of additional professional education, Stavropol State Medical University of the Ministry of Healthcare of Russia. Address: 355017, Stavropol, 310 Mira St.
E-mail: aza.doxkaeva.94@mail.ru


Similar Articles

Back to Content

Бионика Медиа